Key Takeaways
- • Australian venture funding in Q2 2026 totaled $1.7 billion across 64 deals, marking the lowest deal count in six years despite headline strength, with venture rounds declining 21% sequentially from Q1.
- • Two mega-rounds—Firmus ($725 million) and Airwallex ($460 million Series H)—accounted for approximately 70% of quarterly capital deployed, creating the widest recorded gap between headline funding figures and underlying market activity.
- • The remaining 62 venture rounds shared only $500 million in capital, with sub-$5 million rounds hitting their lowest level on record, signaling severe contraction in early-stage deal-making beneath the surface.
- • The third-largest deal, Liquid Instruments' Series C, reached only $70 million, underscoring the extreme concentration of capital in late-stage rounds and the scarcity of mid-market opportunities.
- • Cut Through Venture founder Chris Gillings characterized the quarter as "very slow," highlighting the structural disconnect between aggregate funding totals and actual deal velocity in the Australian startup ecosystem.
Summary
Australian venture capital experienced a sharp contraction in deal activity during the June quarter despite maintaining a strong first-half funding total, revealing a significant divergence between headline capital figures and market-level deal-making. According to Cut Through Venture's latest quarterly report, venture rounds fell to 64 in Q2 2026—the lowest quarterly deal count since the firm's dataset began in 2020 and a 21% decline from Q1. This contraction occurred even as the quarter posted $1.7 billion in announced funding, which capped the strongest first half for Australian startup funding since the 2022 boom period.
The quarterly total masks a deeply skewed capital distribution. Firmus and Airwallex accounted for roughly 70% of all capital deployed through just two transactions: Firmus raised $725 million while Airwallex secured $460 million in its Series H round. This two-deal concentration represents what Cut Through Venture describes as "the widest gap between headline funding and market activity on record." The third-largest transaction—Liquid Instruments' Series C—reached only $70 million, indicating an abrupt drop-off in deal sizes beyond the mega-round tier.
The underlying softness becomes apparent when the two largest deals are excluded. The remaining 62 venture rounds collectively deployed $500 million, demonstrating severe early-to-mid stage capital scarcity. Notably, sub-$5 million rounds—a key indicator of early-stage ecosystem health—fell to their lowest level ever recorded in Cut Through Venture's dataset. Chris Gillings, founder of Cut Through Venture, characterized the period as a "very slow quarter," underscoring that aggregate funding metrics do not reflect the actual pace of venture deal-making or the availability of capital for emerging companies below the mega-round threshold.
This structural imbalance reflects a broader market dynamic in which institutional capital has become highly concentrated in proven late-stage platforms, while early-stage founders face a significantly tightened funding environment. The Australian venture market's reliance on occasional blockbuster rounds to generate headline growth masks the reality of deal count compression and reduced capital accessibility for the majority of startups seeking Series A and Series B funding.
The quarterly total masks a deeply skewed capital distribution. Firmus and Airwallex accounted for roughly 70% of all capital deployed through just two transactions: Firmus raised $725 million while Airwallex secured $460 million in its Series H round. This two-deal concentration represents what Cut Through Venture describes as "the widest gap between headline funding and market activity on record." The third-largest transaction—Liquid Instruments' Series C—reached only $70 million, indicating an abrupt drop-off in deal sizes beyond the mega-round tier.
The underlying softness becomes apparent when the two largest deals are excluded. The remaining 62 venture rounds collectively deployed $500 million, demonstrating severe early-to-mid stage capital scarcity. Notably, sub-$5 million rounds—a key indicator of early-stage ecosystem health—fell to their lowest level ever recorded in Cut Through Venture's dataset. Chris Gillings, founder of Cut Through Venture, characterized the period as a "very slow quarter," underscoring that aggregate funding metrics do not reflect the actual pace of venture deal-making or the availability of capital for emerging companies below the mega-round threshold.
This structural imbalance reflects a broader market dynamic in which institutional capital has become highly concentrated in proven late-stage platforms, while early-stage founders face a significantly tightened funding environment. The Australian venture market's reliance on occasional blockbuster rounds to generate headline growth masks the reality of deal count compression and reduced capital accessibility for the majority of startups seeking Series A and Series B funding.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.